Sunday, September 18, 2022 11:23:19 AM
The lead researcher looking into this question is immunogeneticist Jill Hollenbach. She "... and her colleagues at UCSF have been studying people who test positive COVID but show no symptoms. "Not even a sniffle or a scratchy throat," she says. "So they are entirely asymptomatic."
After analyzing DNA from more than 1,400 people, they identified a mutation that helps a person clear out SARS-CoV-2 so fast that their body doesn't have a chance to develop symptoms.
The mutation occurs in a gene called HLA, which is critical during the earliest stages of infection."
Hollenbach doesn't disclose which Human leukocyte antigen (HLA) was mutated, but I think it may be HLA-B27. "HLA-B27 is a blood test to look for a protein that is found on the surface of white blood cells... (HLAs) are proteins that help the body's immune system tell the difference between its own cells and foreign, harmful substances. They are made from instructions by inherited genes."
While in our 20's, both my brother and I contracted Reiter's Syndrome. "Reactive arthritis, also called Reiter's syndrome, is the most common type of inflammatory polyarthritis in young men. It is sometimes the first manifestation of human immunodeficiency virus infection. An HLA-B27 genotype is a predisposing factor in over two thirds of patients with reactive arthritis."
https://www.aafp.org/pubs/afp/issues/1999/0801/p499.html#:~:text=Reactive%20arthritis%2C%20also%20called%20Reiter's,of%20patients%20with%20reactive%20arthritis.
I'm just trying to understand what lenz does. Why might it be an important drug in treating arthritis? More importantly, is a potential Big Pharma partner looking at lenz as a possible cure for arthritis?
Additionally, what does an arthritis drug have to do with treating coronaviruses, including mono? And the answer appears to be that both indications are associated with human immunodeficiency virus infection.
https://www.medrxiv.org/content/10.1101/2022.06.21.22276660v1
https://www.cdc.gov/epstein-barr/index.html
So I ask again, how many lenz patients have suffered breakthrough covid infections?
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM